These promising results of durable responses in patients with advanced cancer also underscore the importance of understanding the roles of the Cyclin D1 in shaping the development of the tumor microenvironment and in the therapeutic efficacy for successful clinical translation in treating patients with cancer. Here, CCND1 is linked to neoplasm.